Shearman Reps Sun Pharma In Long-Sought $600M Taro Buyout
Israel's Taro Pharmaceutical Industries Ltd. has accepted an improved, $39.50 per-share cash offer from majority shareholder Sun Pharmaceutical Industries Ltd. to buy up the rest of the company, the drugmakers announced...To view the full article, register now.
Already a subscriber? Click here to view full article